new_0222_0420|AVTE|0|ps_ratio|price_to_book_value|peg_ratio|price|short_interest|dividend_yield|earning_yield|market_cap|pe_ratio|consensus_recommendation|price_target_num_est|price_target|sales_est_1y|sales_est_0y|eps_est_1y|eps_est_0y|ebitda_est_0y|ebitda_est_1y|revenues|ebitda|net_income|price_next_month|price_second_month
new_0222_0420|AVTE|1|Aerovate Therapeutics Inc PS Ratio|Aerovate Therapeutics Inc Price to Book Value|Aerovate Therapeutics Inc PEG Ratio|Aerovate Therapeutics Inc Price (USD)|Aerovate Therapeutics Inc Short Interest|Aerovate Therapeutics Inc Dividend Yield|Aerovate Therapeutics Inc Earnings Yield|Aerovate Therapeutics Inc Market Cap (USD)|Aerovate Therapeutics Inc PE Ratio|Aerovate Therapeutics Inc Consensus Recommendation|Aerovate Therapeutics Inc Price Target Num Estimates|Aerovate Therapeutics Inc Price Target (USD)|Aerovate Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Aerovate Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Aerovate Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Aerovate Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Aerovate Therapeutics Inc EBITDA Estimates for Current Fiscal Year (USD)|Aerovate Therapeutics Inc EBITDA Estimates for Next Fiscal Year (USD)|Aerovate Therapeutics Inc Revenue (Quarterly) (USD)|Aerovate Therapeutics Inc EBITDA (Quarterly) (USD)|Aerovate Therapeutics Inc Net Income (Quarterly) (USD)||
new_0222_0420|AVTE|2|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_price|figure_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_whole_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0420|AVTE|4|quarterly|daily|quarterly|daily|monthly|daily|daily|daily|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0420|AVTE|5||1.4387755102||1.43827160494|15.3571428571|1.43827160494|1.43827160494|1.43827160494||15.9230769231|18.8181818182|18.8181818182|22.2222222222|33.3333333333|28.5714285714|39.8||||91.3333333333|91.3333333333||
new_0222_0420|AVTE|6||98||162|14|162|162|162||13|11|11|9|6|7|5||||6|6||
new_0222_0420|AVTE|7|daily|daily|daily|market_daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly||
new_0222_0420|AVTE|20200315||||||||||||||||||||-1.398|-1.436||
new_0222_0420|AVTE|20200615||||||||||||||||||||-1.625|-2.202||
new_0222_0420|AVTE|20200915||||||||||||||||||||-2.243|-2.307||
new_0222_0420|AVTE|20201215||||||||||||||||||||-4.309|-3.666||
new_0222_0420|AVTE|20210315||||||||||||||||||||-2.779|-2.781||
new_0222_0420|AVTE|20210615||||22.83|||-9.7794|527.5579||||||||||||-5.772|-5.775||
new_0222_0420|AVTE|20210715||||19.41|416828||-11.5025|448.5282||1|1|30|||-4.56|-0.41||||||19.94|12.85
new_0222_0420|AVTE|20210815||||13.8|735600||-16.1785|336.8635||1|3|24.6667|||-2.61|-0.63||||||13.47|17.09
new_0222_0420|AVTE|20210915||2.8476||18.18|849095||-12.2807|443.7811||1|3|24.6667|||-2.61|||||-6.197|-6.184|18.62|20.98
new_0222_0420|AVTE|20211015||2.7105||19.97|330935||-9.7424|487.4757||||||||||||||18.75|15.93
new_0222_0420|AVTE|20211115||2.1255||15.66|363660||-12.4238|382.2669||1|3|24.6667|||-2.61|-0.86||||||15.9|13.71
new_0222_0420|AVTE|20211215||1.8201||13.41|446875||-14.5083|327.3435||1|3|24.6667|||-2.785|-0.86||||||13.06|11.79
new_0222_0420|AVTE|20220115||1.4835||10.93|431121||-17.8002|266.8057||1|3|24.6667||||||||||10.27|11.82
new_0222_0420|AVTE|20220215||1.4401||10.61|||-18.3371|258.9943||1|4|24.5|||-1.1933|-2.2167||||||9.44|8.64